Absorption, metabolism, and excretion of [14C]dersimelagon, an investigational oral selective melanocortin 1 receptor agonist, in preclinical species and healthy volunteers
Abstract Dersimelagon (formerly MT‐7117) is a novel, orally administered nonpeptide small molecule selective agonist for melanocortin 1 receptor currently being investigated for the treatment of erythropoietic protoporphyria, X‐linked protoporphyria, and diffuse cutaneous systemic sclerosis (dcSSc)....
Saved in:
Main Authors: | Minoru Tsuda (Author), Kei Ogawa (Author), Tadashi Endou (Author), Takahiro Goto (Author), Yuko Ogasawara (Author), Akihito Ogasawara (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Melanogenic effect of dersimelagon (MT‐7117), a novel oral melanocortin 1 receptor agonist
by: T. Suzuki, et al.
Published: (2022) -
Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure
by: Shannon Dow, et al.
Published: (2013) -
Preclinical Absorption, Distribution, Metabolism, and Excretion of Sodium Danshensu, One of the Main Water-Soluble Ingredients in Salvia miltiorrhiza, in Rats
by: Xiangguo Meng, et al.
Published: (2019) -
The in vivo process of realgar from absorption to excretion
by: Yan Luo, et al.
Published: (2023) -
Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases
by: Carl Spana, et al.
Published: (2019)